TIG Advisors LLC’s AstraZeneca AZN Stock Holding History

TIG Advisors LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-63,950	Closed	-$6.39M	–	426
2020 Q4	$6.39M	Buy	+63,950	New	+$6.77M	0.32%	44

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TIG Advisors LLC's AZN Position: Q3 2021 in Review

TIG Advisors LLC sold out of AstraZeneca (AZN) in Q3 2021, closing a stake of 50,627 shares — an estimated $6.07M sold.

TIG Advisors LLC first reported a position in AZN in Q3 2014 and held it in 4 quarters. The position peaked at $16M in Q4 2020. 905 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

TIG Advisors LLC reported no remaining AstraZeneca position as of Q3 2021 after selling out during the quarter.
TIG Advisors LLC sold 50,627 AstraZeneca shares in Q3 2021, an estimated $6.07M.
TIG Advisors LLC first reported a position in AstraZeneca in Q3 2014 and held it in 4 quarters.
TIG Advisors LLC's AstraZeneca position peaked at $16M in Q4 2020.
905 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on TIG Advisors LLC's 13F filing for Q3 2021, filed 15 Nov 2021.